Don’t miss our upcoming webinar on new approaches for using native neurons for drug discovery. The Global Web Symposium takes place on May 16, 11:00-12:00 EDT. The topic is “Development of Cell-Based Assays for Pain Drug Discovery Using Native Sensory Neurons” and speakers are Dr Darren Cawkill, Associate Research Fellow at Neusentis (A Pfizer Research Unit) and Dr Paul Karila, VP Discovery Services at Cellectricon.
Cellectricon is creating model systems with native neurons for registering changes in neural activity, both at the cellular and network level. In this webinar, together with one of our valued clients, Neusentis, we will describe how we used native cells with relevance to pain drug discovery to develop an assay with improved physiological relevance over traditional approaches. Neusentis will review these results together with data from an additional phenotypic screening case study, to outline general progress towards high-throughput compatible assays using both primary rat neuronal cultures and human stem cell-derived sensory neurons. We will also discuss how such phenotypic screening assays could be integrated into drug discovery programs.